In Vivo Effects of Recombinant-Interferon-β_1b Treatment on Polymorphonuclear Cell and Monocyte Functions and On T-Cell-Mediated Antibacterial Activity in Patients with Relapsing-Remitting Multiple Sclerosis

References

• Raine C. S. Demyelinating diseases. Textbook of Neuropathology, 2nd ed., R. L. Davis, D. M. Robertson. Williams and Wilkins, Baltimore 1991; 535
   Google Scholar
• Lu C. Z., Jensen M. A., Arnason B. G. Interferon gamma-and interleukin-4-secreting cells in multiple sclerosis. J. Neuroimmunol. 1993; 46: 123
   PubMed Web of Science ®Google Scholar
• Bansil S., Cook S. D., Rohowsky-Kochan C. Multiple sclerosis: immune mechanism and update on current therapies. Ann. Neurol. 1995; 37: 87
   PubMedGoogle Scholar
• Brosnan C. F., Cannella B., Battistini L., Raine C. S. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995; 4: 16
   Google Scholar
• Cannella B., Raine C. S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 1995; 37: 424
   PubMed Web of Science ®Google Scholar
• Shin M. L., Koski C. L. The complement system in demyelination. Myelin: Biology and Chemistry, R E Martenson. CRC Press, Boca Raton 1992; 801
   Google Scholar
• Morgan B. P. Complement in diseases of the central nervous system. Complement in Health and Disease, K. Whaley, M. Loos, J. M. Weiler. Kluwer Academic Press, London 1992; 353
   Google Scholar
• Carlos T. M., Harlan J. M. Leukocyte-endothelium adhesion molecules. Blood 1994; 84: 2068
   PubMed Web of Science ®Google Scholar
• Gerard C., Gerard N. P. C5a anaphylatoxin and its seven transmembranesegment receptor. Annu. Rev. Immunol. 1994; 12: 775
   PubMed Web of Science ®Google Scholar
• Murphy P. M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 1994; 12: 593
   PubMed Web of Science ®Google Scholar
• Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301
   PubMed Web of Science ®Google Scholar
• Cross A. H. Immune cell traffic control and the central nervous system. Semin. Neurosci. 1992; 4: 213
   Google Scholar
• Raine C. S. Multiple sclerosis: immune system molecule expression in the central nervous system. J. Neuropath. Exp. Neurol. 1994; 53: 328
   PubMedGoogle Scholar
• Hugli T. E. Biochemistry and biology of anaphylatoxin. Complement 1986; 3: 111
   PubMedGoogle Scholar
• Oppenheim J. J., Zachariae C. O. C., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene “intecrine” cytokine family. Annu. Rev. Immunol. 1991; 9: 617
   PubMed Web of Science ®Google Scholar
• Wahl S. M., Hunt D. A., Wakefield L. M., McCartney-Francsis N., Wahl I. M., Roberts A. B., Sporn M. B. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci., USA 1987; 84: 5788
   PubMed Web of Science ®Google Scholar
• Brandes M. E., Mai U. E. H., Ohura K., Wahl S. M. TGFβ receptors on neutrophils mediate chemotaxis to TGF-β. J. Immunol. 1991; 147: 1600
   PubMed Web of Science ®Google Scholar
• Morganti-Kossmann M. C., Kossmann T., Brandes M. E., Mergenhagen S. E., Wahl S. M. Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β. J. Neuroimmunol. 1992; 39: 163
   PubMedGoogle Scholar
• Snyderman R., Uhing R. J. Chemoattractant stimulus-response coupling. Inflammation: Basic Principles and Clinical Correlates, J. I. Gallin, I. M. Goldstein, R. Snyderman. Raven Press, New York 1992; 421
   Google Scholar
• Armstrong R., Harvath L., Dubois-Dalcq M. E. Type l astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J. Neurosci. Res. 1990; 27: 400
   PubMedGoogle Scholar
• Yao J., Harvath L., Gilbert D. L., Colton C. A. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res 1990; 27: 36
   PubMed Web of Science ®Google Scholar
• Lacy M., Jones J., Whittemore S. R., Haviland D. L., Wetsel R. A., Barnum S. R. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and fMLP by human astrocytes and microglia. J. Neuroimmunol. 1995; 61: 71
   PubMed Web of Science ®Google Scholar
• Muller-Ladner U., Jones J. L., Wetsel R. A., Gay S., Raine C. S., Barnum S. R. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 1996; 144: 135
   PubMed Web of Science ®Google Scholar
• Panitch H. S. Interferons in multiple sclerosis. Drugs 1992; 44: 946
   PubMedGoogle Scholar
• The IFN-β multiple sclerosis study group. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis, I. Clinical results of a multicenter, randomized, double-blind placebo-controlled trial. Neurology 1993; 43: 655
   Google Scholar
• Noronha A., Toscas A., Jensen M. A. Interferon β decreases T cell activation and interferon γ production in multiple sclerosis. J. Neuroimmunol. 1993; 46: 145
   PubMed Web of Science ®Google Scholar
• Shakir S., Byskosh P. V., Reder A. T. Interferon-β induces interleukin-10 mRNA in mononuclear cells (MNC). Neurology 1994; 44: 211
   Google Scholar
• Panitch H. S., Folus J. S., Johnson K. P. Beta interferon prevents HLA class II antigen induction by gamma interferon in MS. Neurology 1989; 39: 171
   Google Scholar
• Noronha A., Toscas A., Jensen M. A. Interferon beta augments suppressor cell function in multiple sclerosis. Ann. Neurol. 1990; 27: 207
   PubMed Web of Science ®Google Scholar
• Noronha A., Toscas A., Arnason B. G. W., Jensen M. IFN-beta augments in vivo suppressor function in MS. Neurology 1994; 44: 212
   Google Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 1968; 21: 77
   PubMed Web of Science ®Google Scholar
• Haston W. S., Shields J. M. Neutrophil leucocyte chemotaxis: a simplified assay for measuring polarizing responses to chemotactic factors. J Immunol. Methods 1985; 81: 229
   PubMed Web of Science ®Google Scholar
• Mandell L., Hook W. E. Leukocyte function in chronic granulomatous diseases of childhood. Am. J. Med. 1969; 47: 473
   PubMed Web of Science ®Google Scholar
• Antonaci S., Tortorella C., De Simone C., Jirillo E. Role of bacterial lipopolysaccharides in the development of natural antibacterial activity mediated by human peripheral blood T lymphocytes. Intern Rev. Immunol. 1990; 6: 237
   PubMedGoogle Scholar
• Podikoglou D. G., Lianou P. E., Tsakanikas C D., Papavassiliou J. T. Polymorphonuclear leukocyte functions and multiple sclerosis. Neurology 1994; 44: 129
   PubMedGoogle Scholar
• Amati L., Caradonna L., Jirillo E., Caccavo D. Immunological disorders in inflammatory bowel disease and immunoterapeutic implications. Ital. J. Gastroenterol. Hepatol. 1999; 31: 000
   Google Scholar
• Rep M. H., Schrijver H. M., van Lopik T., Hintzen R. Q., Roos M. T., Ader H. J., Polman C. H., van Lier R. A. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interrferon-gamma producing T cells in MS patients. J. Neuroimmunol. 1999; 96: 92
   PubMed Web of Science ®Google Scholar
• North R. J. The concept of activated macrophage. J. Immunol. 1978; 121: 806
   PubMed Web of Science ®Google Scholar
• Karnovsky M. L., Lazdins J. K. Biochemical criteria for activated macrophages. J. Immunol 1978; 121: 809
   PubMed Web of Science ®Google Scholar
• Cohn Z. A. The activation of mononuclear phagocytes: facts, fancy and future. J. Immunol. 1978; 121: 813
   PubMed Web of Science ®Google Scholar
• Djieu J. Y., Blanchard D. K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-γ and tumor necrosis factor. J. Immunol. 1986; 137: 2980
   PubMedGoogle Scholar
• Blanchard D. K., Friedman A., Klein T. W., Djieu J. Y. Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J. Leuk. Biol. 1989; 45: 538
   PubMedGoogle Scholar
• Denis M., Chadee K. Human neutrophils activated by interferon-γ and tumor necrosis factor-α kill Entamoeba histolytica trophozoites in vitro. J. Leuk. Biol. 1989; 46: 270
   PubMed Web of Science ®Google Scholar
• Curfs J. H. A.J., Meis J. F. G. M., Hoogkamp-Korstanje J. A. A. A primer on cytokines: sources, receptors, effects and inducers. Clin. Microbiol. Rev. 1997; 10: 742
   PubMed Web of Science ®Google Scholar